Conclusions drawn from a recent study have pointed to the potential of a novel carotid stent system that could benefit patients at high risk of complications from carotid endarterectomy (CEA).
Coronary stent underexpansion (SU) remains a major challenge in percutaneous coronary intervention (PCI), increasing restenosis and thrombosis risks, according to a new review that proposes an intravascular imaging (IVI)-guided algorithm to systematically optimize stent expansion and improve patient outcomes.
Tricuspid regurgitation (TR) disease stage may influence survival outcomes following tricuspid transcatheter edge-to-edge repair (T-TEER), according to a new analysis of 1-year follow-up data that suggests individuals with intermediate TR may receive the most substantial treatment benefits.
In patients with a history of stroke, salt substitution is safe, and the risks of death and recurring stroke are reduced, a new cluster trial shows.
Among individuals in sexual minority (SM) groups in the US, those with unfavorable social determinants of health (SDOH) profiles have worse cardiovascular health (CVH) scores and are at higher risk for cardiovascular mortality compared with heterosexual individuals, a new study shows.
Mechanical surgical aortic valve replacement (AVR) is independently associated with significant survival benefits compared with bioprosthetic AVR in patients aged 60 years and younger, a real-world analysis shows.
A viewpoint paper explains that equitable performance is the responsibility of health care-providing institutions when integrating artificial intelligence (AI) in clinical practice, as well as continuously developing AI applications to address long-standing inequities.
High out-of-pocket (OOP) costs for heart failure (HF) management continue to create confusion, financial burdens, financial strain and financial toxicity for patients with chronic diseases in the U.S., leading to poor medication adherence and negative health outcomes, authors share in a state-of-the-art review.
In patients with heart failure with preserved ejection fraction (HFpEF), investigator adjudication reports similar accuracy and faster event accumulation compared with the clinical events committee (CEC) when assessing the impact of the Standardized Data Collection for Cardiovascular Trials (SCTI) criteria, an analysis of the EMPEROR-Preserved trial shows.
Bailey G. Salimes, CRTonline.org
Nathan Gray, CRTonline.org
Will Chu, CRTonline.org
Michael Mahmoudi, MD - P Generreux, et al.; NEJM 2025; NEJM 2025; 392:217-227
Michael Mahmoudi, MD - R Hahn et al.; NEJM 2025; 392:115-126
Michael Mahmoudi, MD - K Couper, et al.; NEJM 2025; 392:336-348
Michael Mahmoudi, MD - K Goel, et al.; Circulation 2024; 150:1493-1504
What is your opinion on the collection of biomarkers after PCI?
Routine biomarker monitoring after PCI is not necessary.
At least one biomarker measurement after PCI is important.
Biomarker collection should be limited to patients with complicated PCI.
Soban Ahmad, Muhammad Junaid Ahsan, Morgan Newlun, Mitchell Sand, Anan Abu Rmilah, Amman Yousaf, Muhammad Asim Shabbir, Shahbaz A. Malik and Andrew M. Goldsweig
Rutger-Jan Nuis, Thijmen W. Hokken, Jenna van Niekerk, Lucas Uchoa de Assis, Rik Adrichem, Mark van den Dorpel, Joris Ooms, Isabella Kardys, Mattie Lenzen, Joost Daemen and Nicolas M. Van Mieghem
Francesco Amata, Massimo Ferraro, Antonio Mangieri, Damiano Regazzoli, Giuseppe Ferrante, Ottavia Cozzi, Giulio Stefanini, Bernhard Reimers and Antonio Colombo
Fatima Lakhani, Bertrand Ebner, Chetan Yarlagadda, Polydoros Kampaktsis and Nikolaos Spilias
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details